Human Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret (RET) Protein

546€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Human Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret (RET) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx620271
tested applications
ELISA, WB, SDS-PAGE
Description
Human Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret (RET) Protein is a recombinant Human protein produced in a Mammalian cell expression system.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret (RET) |
Host | Mammalian cells |
Origin | Human |
Conjugation | Unconjugated |
Observed MW | Molecular Weight: Calculated MW: 70.68 kDa Sequence Fragment: Leu29-Arg635 Tag: C-terminal His tag |
Expression | Recombinant |
Purity | > 90% (SDS-PAGE) |
Size 1 | 100 µg |
Size 2 | 1 mg |
Form | Lyophilized Reconstitute in sterile water to produce a stock solution. |
Tested Applications | ELISA, WB, SDS-PAGE |
Buffer | Prior to lyophilization: PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
Availability | Shipped within 5-12 working days. |
Storage | Store at 2-8 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C for long-term storage. Avoid repeated freeze-thaw cycles. |
Dry Ice | No |
UniProt ID | P07949 |
Background | Protein RET |
Note | This product is for research use only. This product is shipped with ice packs. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Human RET (Proto-oncogene tyrosine-protein kinase receptor Ret) ELISA Kit
Ver Producto

Retinol (RET) Antibody
This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene.
Ver Producto